Consensus study sets standards for yearling sales endoscopy

Bottom line

A new Delphi consensus study in Equine Veterinary Journal says expert equine veterinarians in Australia and New Zealand have agreed on a more standardized approach to Thoroughbred yearling sales endoscopy, aiming to restore confidence in a process that had been criticized for inconsistency. In three survey rounds involving 40, then 39, then 37 veterinarians, the panel reached consensus to adopt the Havemeyer grading system for yearling laryngeal function, standardize pre-sale endoscopic technique, and use a four-tier risk framework: grades I and II.1 as low risk, II.2 as low-moderate risk, III.1 as moderate risk, and III.2 or higher as high risk. The paper follows earlier work from the same research group showing that stakeholder concern centered on variable interpretation of “grade 3” scopes and uncertainty about how those findings relate to future racing outcomes. (madbarn.com)

Why it matters: For equine veterinarians working in sales medicine, the consensus gives a clearer, evidence-linked structure for reporting laryngeal findings and discussing risk with clients. That matters because Australasian sales companies had already moved toward implementation after reviewing the research, with Inglis, Magic Millions, and New Zealand Bloodstock rolling out the new system for the 2025 sales season, according to AgriFutures Australia. In practice, that could reduce interobserver variability, improve transparency for buyers and consignors, and better align repository endoscopy findings with likely performance and laryngoplasty risk. (agrifutures.com.au)

What to watch: Watch for broader validation of the risk categories in live sales settings, and for whether standardized technique and the Havemeyer scale continue to gain traction beyond Australasia. (madbarn.com)

Key facts

Study type
Delphi consensus study
Journal
Equine Veterinary Journal
Region
Australia and New Zealand
Participants
40, 39, and 37 veterinarians across three survey rounds
Consensus threshold
At least 75%
Main changes
Adopt the Havemeyer grading system and standardize pre-sale endoscopic technique
Risk framework
I and II.1 low risk; II.2 low-moderate risk; III.1 moderate risk; III.2 or higher high risk
Prior concern
Variable interpretation of "grade 3" scopes and uncertainty about future racing outcomes
Industry uptake
Inglis, Magic Millions, and New Zealand Bloodstock rolled out the new system for the 2025 sales season

A newly published Delphi consensus study is trying to bring more consistency to one of the most commercially sensitive parts of the Thoroughbred yearling exam: pre-sale upper airway endoscopy. Writing in Equine Veterinary Journal, Josephine L. Hardwick, Benjamin J. Ahern, Brian H. Anderson, and Samantha H. Franklin report that expert equine veterinarians in Australia and New Zealand reached consensus on a standardized way to grade yearling laryngeal function, assess risk, and perform pre-sale endoscopy. The goal is straightforward: reduce confusion, improve transparency, and rebuild industry confidence in sales scoping. (madbarn.com)

That confidence had been under pressure for some time. A 2024 stakeholder study from the same research group found that veterinarians, breeders, and buyers all raised concerns about two recurring problems: interobserver variability, meaning different veterinarians could assign different grades to the same exam, and uncertainty about what intermediate grades actually mean for future performance. In particular, the old five-point Lane system left a lot of commercial tension around “grade 3” findings, which could carry major sale implications without giving buyers a precise sense of risk. (researchportal.murdoch.edu.au)

The new consensus study used a modified Delphi process, with agreement predefined as at least 75%. Three rounds were completed, with participation of 40 veterinarians in round one, 39 in round two, and 37 in round three. The panel agreed on three core changes: adoption of the Havemeyer grading system, standardization of pre-sale endoscopic technique, and a four-tier risk-rating model tied to yearling laryngeal function grades. Under that model, grades I and II.1 are low risk, grade II.2 is low-moderate risk, grade III.1 is moderate risk, and grade III.2 or higher is high risk. The authors say the framework is intended to improve consistency and support better-informed purchasing decisions. (madbarn.com)

The technical standardization piece is important in its own right. Existing Equine Veterinarians Australia guidance already called for specific video endoscopy practices, including recording the examination in a compatible format and capturing three swallowing reflexes that clearly show arytenoid abduction and laryngeal evaluation. The Delphi paper builds on that push for uniform technique, which is critical if clinicians want grading systems to be reproducible across veterinarians, sales grounds, and repositories. (content.inglis.com.au)

The broader research program helps explain why this consensus landed now. AgriFutures Australia said the project ran from 2022 to 2024 and included review of more than 5,000 sales endoscopic videos, paired with follow-up on racing performance. According to that account, the Havemeyer system’s seven grades offered more discrimination than the older five-point scale, especially within the former “grade 3” bucket. AgriFutures quoted Hardwick saying the team found a difference in race performance between yearlings graded II.2 and III.1 under Havemeyer, even though both would previously have been labeled grade 3 under the Lane system. (agrifutures.com.au)

Industry reaction appears supportive. AgriFutures reported that Inglis, Magic Millions, and New Zealand Bloodstock, together with their consulting veterinarians, reviewed the findings in late 2024 and implemented the new grading approach for the 2025 sales season. Jonathan D’Arcy of Inglis said the research gave buyers more confidence and helped the industry move forward with less disagreement around borderline scopes. That’s not an independent expert comment, but it is a useful signal that the commercial side of the Australasian bloodstock market sees the new framework as practical, not just academic. (agrifutures.com.au)

Why it matters: For veterinary professionals, this is less about a new test than about a more defensible way to use an existing one. Sales endoscopy sits at the intersection of clinical judgment, client communication, legal-commercial expectations, and animal welfare. A consensus-backed grading and risk framework may help veterinarians explain findings with more nuance, reduce disputes over ambiguous intermediate grades, and support more consistent repository reporting. It also reflects a broader trend in equine sales medicine toward linking screening findings to outcome data, rather than relying on tradition or local convention alone. (madbarn.com)

What to watch: The next question is whether prospective use of the framework confirms the promised gains in consistency and predictive value. Expect attention on real-world uptake across sales companies and veterinary teams, on whether the four-tier risk categories hold up as more horses race or undergo laryngoplasty, and on whether other regions adopt similar evidence-based standards for yearling airway assessment. (madbarn.com)

Like what you're reading?

The Feed delivers veterinary news every weekday.